Clinical Trial Update: Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the INTERCEPT Blood System for red blood cells in complex cardiac surgery patients has completed, with results posted assessing effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• INTERCEPT Blood System for Red Blood Cells

Snippet

Sponsor: Cerus Corporation | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2025-09-10